癌症干细胞衍生的细胞外囊泡对瘤免疫微环境的调节效应
Xinyu Li1,2, Cuilian Zhang3, Wei Yue4,5,6
1Department of Animal Science, College of Animal Science, Hebei North University, Zhangjiakou, Hebei, China.
Frontiers in immunology
|July 4, 2024
概括
癌症干细胞 (CSC) 通过细胞外囊泡 (EV) 与免疫细胞进行通信,影响瘤生长和治疗抵抗力. 了解这种相互作用揭示了癌症免疫治疗的新治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤的开始,转移,复发和治疗耐药性.
- 癌细胞和瘤免疫微环境相互相互作用,影响癌症进展和治疗疗效.
研究的目的:
- 审查CSC和免疫细胞之间的EV介导通信.
- 探索针对这种CSC-免疫细胞相互作用的治疗策略.
主要方法:
- 文献综述侧重于细胞外囊泡 (EV) 介导的细胞间通信.
- 分析详细介绍EVs对瘤微环境中的CSC和免疫细胞的影响的研究.
主要成果:
- 细胞外囊泡 (EVs) 是转移生物活性分子在CSC和免疫细胞之间的关键介质.
- EVs重塑了瘤免疫微环境,促进了CSC的生存和传播.
- 这种沟通有助于CSC免疫逃生机制.
结论:
- 在瘤微环境中的CSC-免疫细胞交叉中,EV介导的通信至关重要.
- 准EV相互作用为克服癌症治疗耐药性和免疫逃避提供了潜在的治疗途径.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
10:09Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
6.8K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
